US 8853252
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
granted A61KA61K31/415A61P
Quick answer
US patent 8853252 (Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes) held by Jenrin Discovery, LLC expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Jenrin Discovery, LLC
- Grant date
- Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K31/415, A61P, A61P1/00, A61P1/16